AccuGene
AccuGene is a South Korean molecular diagnostics company that designs and manufactures proprietary DNA/RNA sample collection kits, magnetic-bead extraction reagents, automated extraction instruments, LIMS software, and microbiome analysis services for hospitals, research labs, and genetic testing OEMs worldwide, with US operations in San Diego, Denver, and Virginia.
- Company typePrivate
- Founded2014
- HeadquartersIncheon, South Korea
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What AccuGene does
AccuGene (legal name: AccuGene, Inc.; Korean: (주)어큐진) is a privately-held South Korean molecular diagnostics company founded in 2014 and headquartered in Songdo, Incheon. The company operates across the full sample-to-report workflow in genetic testing, producing proprietary sample collection kits (AccuSaliva, AccuStool, AccuBuccal, AccuViral, AccuBlood, etc.), magnetic bead-based nucleic acid extraction reagents (HiAccuBead, AccuSenseBead), preparation kits for downstream PCR/NGS applications, and the AccuFAST automated extraction instrument. It complements these products with the AccuLIMS laboratory information management system (integrated with Illumina MiSeq sequencers and JANUS liquid handlers), the AccuMAP microbiome analysis web platform, and consumer-facing microbiome services branded Gut Morning and ORAL CARE.
The company monetizes through a hybrid model: (1) one-time hardware and consumable sales to hospitals, clinics, research labs and biotech companies; (2) customized white-label/OEM kit manufacturing sold to genetic testing service providers such as Macrogen, Psomagen, EDGC, Genece, Diagnomics, HelixFit and others at minimum 100-unit order quantities; (3) professional services including NGS library preparation, 16S/18S/ITS microbiome analysis, nucleic acid extraction, sample clean-up, and PCR analysis; (4) subscription/recurring LIMS software revenue; and (5) clinical diagnostic services via the Denver CLIA lab launched in 2023. Go-to-market combines 25+ domestic and 9+ international distributors, direct field sales in Korea, and wholly-owned US regional offices (San Diego, Denver, Virginia). Regulatory assets include FDA 510(k) registrations, an FDA EUA for the AccuViral Collection Kit, MFDS approvals for 8+ preparation kits, ISO 13485:2016, and CLIA certification, all of which support clinical-grade positioning in both Korean and US markets.
AccuGene firmographics
Firmographics- Name
- AccuGene
- Legal name
- AccuGene, Inc.
- Website
- https://accugenelab.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- AccuGene is a South Korean molecular diagnostics company that designs and manufactures proprietary DNA/RNA sample collection kits, magnetic-bead extraction reagents, automated extraction instruments, LIMS software, and microbiome analysis services for hospitals, research labs, and genetic testing OEMs worldwide, with US operations in San Diego, Denver, and Virginia.
- Ownership category
- akta.pro rank
AccuGene industry classification
Industry- Product category
- Molecular Diagnostics
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516), Medical Laboratories (621511), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (423450)
- SIC
- Laboratory Analytical Instruments (3826), In Vitro & In Vivo Diagnostic Substances (2835), Services-Testing Laboratories (8734), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics) (HLAHAAAN)
- akta.pro secondary industries
- Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF), Laboratory Consumables & Plasticware (Tips, Tubes, Plates, Filters) (HLAGAIAH), Molecular Diagnostics & Genomics Laboratories (HLAFAMAE), Diagnostic & Laboratory Packaging (Specimen Containers, Transport Tubes) (IMALAIAF)
Keywords
Where AccuGene is headquartered
LocationHeadquarters
- HQ city
- Incheon
- HQ country
- South Korea
- HQ region
- Asia
Offices4 records
Markets served
AccuGene business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Molecular Diagnostic Kits: Sale of proprietary molecular diagnostic reagents and kits including AccuReagent (HiAccuBead, AccuSenseBead), AccuCollection (various sample collection kits), AccuPrep (DNA preparation kits), and AccuFASTprep kits for automated extraction. One-time product sales with recurring reorder potential.
- Laboratory Equipment: Sale of AccuFAST automation machine for automated nucleic acid extraction. Capital equipment sales with耗材 (consumables) follow-on revenue.
- Microbiome Analysis Services: Gut microbiome analysis (Gut Morning), oral microbiome analysis (ORAL CARE), and 16S/18S/ITS microbiome analysis services using NGS technology. Provides personalized health solutions based on microbiome profiles.
- Customized Laboratory Services: Nucleic acid extraction services, sample clean-up services, PCR analysis services (singleplex/multiplex PCR, qPCR array), and NGS library preparation services for research and clinical purposes.
- White-Label OEM Kits: Customized white-label sample collection kits (saliva, buccal, stool) sold to other genetic testing service providers who rebrand and sell under their own brand. Volume-based B2B sales model.
- LIMS Software Services: AccuLIMS laboratory information management system providing database management for lab workflows, NGS device synchronization, and web-based analysis pipelines.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | White-Label Kit Orders |
Go-to-market motion2 records
Distribution channels5 records
Marketing channels4 records
AccuGene product offering
Product offeringCore offering
AccuGene manufactures and sells molecular diagnostic reagents, DNA/RNA sample collection kits, automated nucleic acid extraction equipment, and laboratory information management software, complemented by microbiome analysis services (gut and oral) and customized NGS laboratory services. The company also provides white-label/OEM sample collection kits to other genetic testing companies that rebrand them for their own consumer genetic testing services.
Product overview
AccuGene is a molecular diagnostics company offering an integrated portfolio of biological sample collection kits, nucleic acid extraction reagents, automated extraction equipment, laboratory information management systems, and microbiome analysis services. The product portfolio consists of four main reagent/preparation kit lines (AccuReagent, AccuCollection, AccuPrep, AccuFASTprep), a laboratory automation instrument (AccuFAST Automation Machine), accessories (sealing films, collection swabs), and software platforms (AccuLIMS for lab management, AccuMAP for microbiome analysis). Services include customized molecular diagnostics, NGS library preparation, microbiome analysis (Gut Morning intestinal, ORAL CARE oral, 16S/18S/ITS academic), nucleic acid extraction, sample cleanup, and white-label kit manufacturing. The AccuFAST automation system connects with AccuFASTprep kits for high-throughput DNA/RNA extraction, while AccuLIMS integrates with sequencing equipment (Illumina MiSeq, JANUS) and AccuMAP provides the customer-facing web platform for microbiome analysis results.
Differentiator
Problem solved
Functional benefit
Brands
- AccuMAP: AccuGene Microbiome Analysis Platform - web-based platform for microbiome analysis, sequencing results management, and custom reporting
- Gut Morning
- ORAL CARE
- AccuLIMS
Companies that use AccuGene
Customer profileNamed customers11 records
Segments4 records
Ideal customer profiles4 records
AccuGene technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
Feature6 records
AccuGene partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core, major and minor.
- Illumina, Inc.coreAccuGene has integrated Illumina's MiSeq sequencing system into their service offerings. The company introduced the Illumina MiSeq System in 2018 and has optimized their LIMS (AccuLIMS) for synchronization with MiSeq devices, enabling automated workflow management for NGS experiments and analysis.
- Korean Domestic Distributors (25+)majorExtensive network of 25+ domestic distributors in South Korea for product distribution. Distributors include multiple companies (names displayed as logos on company website) selling AccuGene's molecular diagnostic kits and equipment throughout the Korean market.
- International Distributors (9+)majorNetwork of 9+ international distributors including Genece serving global markets across US, Canada, and other countries. Distributors extend AccuGene's market reach beyond South Korea and US direct operations.
- PsomagencoreGlobal genetic testing service provider utilizing AccuGene's white-label saliva and stool collection kits. Psomagen rebrands and sells AccuGene's sample collection products under their own brand for consumer genetic testing services.
- EDGCcoreGenetic testing company using AccuGene's buccal collection kits as white-label products. EDGC integrates AccuGene's sample collection solutions into their genetic testing service offerings.
- GenecemajorInternational distributor for AccuGene products. Genece logo appears in the international distributor section of AccuGene's website, indicating a distribution partnership for international markets.
- MacrogenmajorMajor Korean genomics company utilizing AccuGene's kit products. Macrogen operates as both a customer and potential distributor of AccuGene's molecular diagnostic products.
- Korea Institute for the Advancement of Technology (KIAT)coreKIAT has selected AccuGene as a company that supports innovative growth of small and medium venture companies for 'Gut Microbiome Analysis Service' in BIG3 Sectors. Partnership for government-supported innovation projects.
- SMTECHminorSMTECH selected AccuGene as a promising company in the market expansion project for small and mid-sized venture companies. Project focuses on oral microbiome analysis service development for disease diagnosis.
- Incheon Techno ParkcoreAccuGene was selected as a task agency by Incheon Techno Park for establishing a standardized platform for next-generation genome precision medicine.
- Korean Health Industry Development Institute (KHIDI)coreSelected as task agency by KHIDI for secondary performance improvement of AccuFAST Automation Machine and strengthening overseas marketing capability of the product.
Scale indicators3 records
Recent moves11 records
Expansion highlights6 records
AccuGene competitors and assessment
Company assessmentDirect peers
- Zymo Research: Zymo Research offers DNA/RNA extraction kits, sample collection devices, and microbiome analysis services, directly competing across AccuGene's full product stack including microbiome (Gut Morning equivalent) offerings.
- Promega: Promega manufactures nucleic acid purification reagents (Wizard, Maxwell automation systems) and sample-prep chemistries used in clinical genomics — closely comparable to AccuGene's magnetic bead and prep kit lines.
- Norgen Biotek: Norgen Biotek offers sample collection, preservation, and nucleic acid isolation kits for stool, saliva, urine, blood — overlapping with AccuGene's AccuCollection and stool/saliva/buccal sample preparation portfolio.
- Qiagen: Qiagen is a global leader in nucleic acid extraction/sample preparation kits (QIAamp, QIAcube automation) and molecular diagnostics — directly overlapping with AccuGene's AccuReagent/AccuFAST prep kits and bead-based extraction technology.
- Macherey-Nagel: Macherey-Nagel's NucleoSpin and NucleoMag kits are benchmarks for DNA/RNA extraction in research and clinical labs — a direct international competitor to AccuGene's AccuPrep/AccuReagent portfolio.
- Omega Bio-tek: Omega Bio-tek specializes in DNA/RNA extraction kits (E.Z.N.A. line) and magnetic-bead-based sample prep — directly competitive with AccuGene's bead technology and prep kit product family.
Broad incumbents
- Illumina: Illumina is both an AccuGene integration partner (MiSeq into AccuLIMS) and a broader incumbent whose sequencing platforms and growing sample-prep portfolio anchor the same molecular diagnostics workflows AccuGene serves.
- bioMérieux / BioFire Diagnostics: bioMérieux and BioFire's FilmArray sample-to-answer systems are downstream-adjacent competitors to AccuGene's clinical sample prep/reagent business in IVD and infectious disease testing.
- Thermo Fisher Scientific (Invitrogen / PureLink): Thermo Fisher's Invitrogen and PureLink reagent lines, plus KingFisher automation, compete directly with AccuFAST and AccuReagent; broader life-sciences portfolio gives them bundling leverage AccuGene cannot match.
- Beckman Coulter Life Sciences (Danaher): Beckman's automated sample preparation platforms (Biomek, Echo) and nucleic acid kits compete with AccuGene's AccuFAST and reagent lines as part of a much broader workflow product portfolio.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
AccuGene social profiles
Digital presenceAccuGene compliance and trust
Trust signalCompliance5 records
AccuGene financial estimates
Financial estimateRevenue estimate
Valuation estimate
AccuGene leadership team
Management profileNumber of profiles
Profiles1 record
AccuGene subsidiaries and ownership
Company hierarchySubsidiaries1 record
AccuGene funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
AccuGene M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about AccuGene
What does AccuGene do?
AccuGene manufactures and sells molecular diagnostic reagents, DNA/RNA sample collection kits, automated nucleic acid extraction equipment, and laboratory information management software, complemented by microbiome analysis services (gut and oral) and customized NGS laboratory services. The company also provides white-label/OEM sample collection kits to other genetic testing companies that rebrand them for their own consumer genetic testing services.
Is AccuGene a public or private company?
AccuGene is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was AccuGene founded?
AccuGene was founded in 2014. It employs 1 to 10 people.
Where is AccuGene based?
AccuGene is headquartered in Incheon, South Korea, in the Asia region.
How does AccuGene make money?
Six revenue lines are on record. Molecular Diagnostic Kits are the primary driver. The others are laboratory Equipment, microbiome Analysis Services, customized Laboratory Services, white-Label OEM Kits and LIMS Software Services.
Who are AccuGene's main competitors?
Direct peers on record are Zymo Research, Promega, Norgen Biotek, Qiagen, Macherey-Nagel and Omega Bio-tek. Broad incumbents are Illumina, bioMérieux / BioFire Diagnostics, Thermo Fisher Scientific (Invitrogen / PureLink) and Beckman Coulter Life Sciences (Danaher).
Does AccuGene have an API?
No public API is recorded for AccuGene.
What industry is AccuGene in?
AccuGene's product category is Molecular Diagnostics. Its primary akta.pro industry code is HLAHAAAN, Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics), with a secondary code of HLAGAIAF, Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays). Its NAICS code is 325413 and its SIC code is 3826.